Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ITK inhibitors(Tyrosine-protein kinase ITK/TSK inhibitors), JAK3 inhibitors(Tyrosine-protein kinase JAK3 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alopecia Areata | Phase 1 | US | 17 Jun 2022 | |
Vitiligo | Phase 1 | US | - |
Not Applicable | - | cdcyfubljn(rujwglzsxj) = fxgradheys poztkqkheu (ufraktafyn ) View more | - | 07 Jul 2023 | |||
cdcyfubljn(rujwglzsxj) = tjjiwcfemw poztkqkheu (ufraktafyn ) |